SCHEMBL1720062

SCHEMBL1720062

COC(=O)N1CCC(c2noc3[nH]c(=O)c4ccccc4c23)CC1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 3/20 0.41
PER2 O15055 1/20 0.39
CRY1 Q16526 1/20 0.39
CRY2 Q49AN0 1/20 0.39
TNKS O95271 1/20 0.39
PARP2 Q9UGN5 1/20 0.39
TLR8 Q9NR97 1/20 0.38
TLR7 Q9NYK1 1/20 0.38
PDE10A Q9Y233 2/20 0.37
ROCK2 O75116 1/20 0.36
ROCK1 Q13464 1/20 0.36
BRD4 O60885 1/20 0.36
IRAK4 Q9NWZ3 1/20 0.36
NPC1 O15118 1/20 0.36
RAB9A P51151 1/20 0.36
KDM4E B2RXH2 2/20 0.35
RXFP1 Q9HBX9 1/20 0.35
ALDH1A1 P00352 1/20 0.35
GLA P06280 1/20 0.35
PKM P14618 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1720663 0.90 ALDH1A1 (0.47) PARP1KDM4ERXFP1ALDH1A1
SCHEMBL1720278 0.83 PARP1 (0.49) PARP1
SCHEMBL1719871 0.81 PARP1 (0.63) PARP1
SCHEMBL1719647 0.77 PARP1 (0.39) PARP1
Hydrochloric Acid SCHEMBL1719910 0.76 PARP1 (0.38) PARP1TNKS
SCHEMBL10580308 0.71 KDM4E (0.49) PDE10ABRD4NPC1RAB9AKDM4E
SCHEMBL1720231 0.70 BRD4 (0.44) PDE10ABRD4NPC1RAB9AALDH1A1
SCHEMBL1720065 0.69 PARP1 (0.71) PARP1KDM4ERXFP1ALDH1A1
SCHEMBL12786014 0.68 ALDH1A1 (0.59) PARP1ROCK2ROCK1KDM4EALDH1A1
SCHEMBL31073550 0.66 KCNH2 (0.56) BRD4NPC1RAB9AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1566380-B1 ISOQUINOLINE COMPOUNDS AND MEDICINAL USE THEREOF MITSUBISHI TANABE PHARMA CORP (JP) 2012-01-11 EP disclosed
US-7501412-B2 Isoquinoline compounds and medicinal use thereof MITSUBISHI TANABE PHARMA CORPORATION (JP) 2009-03-10 US disclosed
US-20060094743-A1 Isoquinoline compounds and medicinal use thereof MITSUBISHI PHARMA CORPORATION (JP) 2006-05-04 US disclosed
EP-1566380-A1 ISOQUINOLINE COMPOUNDS AND MEDICINAL USE THEREOF Mitsubishi Pharma Corporation (JP) 2005-08-24 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060094743-A1 Isoquinoline compounds and medicinal use thereof PARP1, NQO1, PARP3 PARP1 1/4885PER2 4089/4885CRY1 4421/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.